Palliative care discussions often don’t take place until the patient is far along in their diseases stage and at that point is it mostly about pain management. By utilizing palliative services, patients can receive better care, experience fewer readmissions and better understand their plan and goals of care. In this Keynote, discuss how palliative care and oncology management work hand-in-hand to increase patient satisfaction while reducing costs through preemptive actions.
- Discuss how palliative care can be incorporated into oncology management to reduce readmission, prioritize patient goals, and better engage family members in the treatment course
- Coordinate social workers, home visits, nutritionists, psychosocial care early on
- Evaluate how to establish a program and expand it to make it more robust
President and Chief Executive Officer
Regional Cancer Care Associates
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey
Quality metrics used in oncology care are traditionally focused on processes and outcomes which often makes it harder for payers to identify high value providers and measure overall care benchmarks. Being able to determine these providers and further collaborate with them has the potential to increase timely care while being cost effective for both payers and providers.
- Understand what payer organizations are looking for in terms of data that translates to high performance
- Adapt outcome-based measurements that can be meaningful and show how providers are managing specific diagnoses
- Create strategies to continuously move the bar forward on quality improvement initiatives
Chief Quality Officer
UPMC Health Plan
Director, Oncology Value Creation
The rise of value-based reimbursement for cancer care challenges providers to take on a more holistic responsibility for their patient to improve quality and affordability of care. It is crucial for oncology practices to better understand total cost of care, reduce avoidable and costly hospital admissions and create efficient drug cost management strategies. In this session, understand what are the steps necessary for a practice to deliver high value cancer care and lower utilization and expenditures without sacrificing quality.
- Analyze where the cost drivers are in oncology management for a practice
- Access a practice’s readiness to transform into a value-based practice
- Optimize infusion center function and create nursing triage pathways to mitigate costs
- Outline successful strategies to operationalize a high value practice and deliver value-based cancer care
Section Head, Hematology-Oncology; Program Director, Oncology Care Model
The impact of a cancer diagnosis can be devastating. Managing doctor appointments, treatment regiments, and insurance providers is overwhelming for both the patients and their families. Although treatment plans that are integrated, comprehensive, and focused on the patient are available, this focus is not always extended to the patient billing process. In this session, discuss the impact that treatment costs have on the patient, the power of a comprehensive and fully integrated billing process, and trends that address both patient experience and the cost to collect. Learn how the fourth largest oncology provider in the U.S. leveraged patient engagement, technology, and a cohesive outreach program to improve their billing process and patient health.
- Uncover key components every patient responsibility strategy needs
- Learn how to provide patients and their families with the information they need without overwhelming them
- Adapt real world application of consumer trends to improve patient engagement
- Move beyond patient financing and provide more valuable payment options
President; Chief Executive Officer
In the past year, the interest in biosimilars for oncology treatment soared across the nation as biosimilars for different disease conditions received FDA approval. The increasing number of approvals is closely supported by the growing demand for cost effective oncology treatments. Moreover, the high development cost and regulatory hurdles for commercialization have slowed the adoption of biosimilars in the U.S. market.
- Uncover the provider level of comfort in adapting biosimilar oncology therapies
- Review currently available biosimilars and the short-term forecast
- Evaluate how adoption of biosimilars will affect providers, payers, and patients financially
Director, Pharmacy Cancer Care; Assistant Professor of Pharmacy,
Clinical Specialty Pharmacist
Advocate Aurora Health Care, Advocate Physician Partners
Specialty drugs used in cancer treatment are high-cost and high-touch medications that are complex to manufacture and administer. Through better collaboration and communication, enhanced patient services and therapy management programs, specialty pharmacy can present itself as a patient-centric treatment option that will lead to better outcomes. In this session, analyze the emerging trends and hurdles of specialty pharmacy in cancer treatment and its role in value-based care.
- Discuss new therapies in the market and the role of specialty providers
- Evaluate how specialty pharmacy impacts value-based treatment goals
Senior Director, Patient Care and Advocacy for Oncology, Fertility and Multiple Sclerosis
The wide variety of data across different markets prevents health systems from efficiently combining and comparing practice-related data. Consolidating all regional databases into a central data center would provide the ability to optimize workflow. In this session, learn how Bon Secours Mercy Health standardized workflow, compiled practice-related data and seized financial opportunities.
- Discover strategies to secure buy-in from stakeholders and team members
- Outline the process of moving data from multiple locations to a central data center
- Identify and remove implementation barriers
Regional Director, Oncology Services, Great Lakes Group, Youngstown Region
Bon Secours Mercy Health